Drug Shortage Report for ALKERAN
Report ID | 118933 |
Drug Identification Number | 02087286 |
Brand name | ALKERAN |
Common or Proper name | Alkeran Injection / Melphalan |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MELPHALAN BUFFER SOLUTION |
Strength(s) | 50MG 10ML |
Dosage form(s) | KIT POWDER FOR SOLUTION SOLUTION |
Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
Packaging size | 1 vial |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-30 |
Estimated end date | 2021-12-01 |
Actual end date | 2021-11-04 |
Shortage status | Resolved |
Updated date | 2021-11-05 |
Company comments | GR80016CA1 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v29 | 2021-11-05 | English | Compare |
v28 | 2021-11-04 | French | Compare |
v27 | 2021-11-04 | English | Compare |
v26 | 2021-09-28 | French | Compare |
v25 | 2021-09-28 | English | Compare |
v24 | 2021-09-28 | French | Compare |
v23 | 2021-09-28 | English | Compare |
v22 | 2021-09-14 | French | Compare |
v21 | 2021-09-14 | English | Compare |
v20 | 2021-09-14 | French | Compare |
v19 | 2021-09-14 | English | Compare |
v18 | 2021-09-14 | English | Compare |
v17 | 2021-09-03 | French | Compare |
v16 | 2021-09-03 | English | Compare |
v15 | 2021-05-01 | English | Compare |
v14 | 2021-03-24 | French | Compare |
v13 | 2021-03-24 | English | Compare |
v12 | 2021-03-24 | French | Compare |
v11 | 2021-03-24 | English | Compare |
v10 | 2021-02-02 | English | Compare |